Oncology & Cancer

Adverse effects from cancer drug trials explained

A team of researchers investigating how a certain type of drugs can kill cells has discovered that these drugs can do more harm than good when used in combination with other cancer treatments.

Oncology & Cancer

Outcomes equal for AYA Hodgkin therapy at peds, adult centers

(HealthDay)—For adolescent and young adult (AYA) patients with Hodgkin lymphoma (HL), treatment strategies differ, but outcomes are equivalent with treatment at pediatric and adult centers, according to a study published ...

Oncology & Cancer

Cancer survival rates improve for young adults

A new study in the Journal of the National Cancer Institute, published by Oxford University Press, finds improvements in five-year survival rates for all cancers in young adults. For some cancers, however, there has been ...

Oncology & Cancer

Young cancer survivors at higher risk for hospitalization

(HealthDay)—Adolescent and young adult (AYA) cancer survivors (aged 15 to 39 years) have an increased risk for inpatient hospitalization, according to a study published online Jan. 20 in Cancer Epidemiology, Biomarkers ...

page 6 from 17